Walgreens Partners Buckeye Health Plan To Offer Expanded Health And Wellness Services

RTTNews | 917日前
Walgreens Partners Buckeye Health Plan To Offer Expanded Health And Wellness Services

(RTTNews) - Walgreens Health, a division of Walgreens Boots Alliance, Inc. (WBA), announced Tuesday a new collaboration with Buckeye Health Plan to bring innovative health and wellness services to Medicaid members in five northeast Ohio neighborhood locations this summer.

Buckeye Health Plan, an Ohio managed care company, is the third payer to partner with Walgreens Health to launch Walgreens Health Corner locations.

With additional partners in California and New Jersey across commercial and Medicare plan patient populations respectively, Walgreens Health is now contracted to serve more than 2.27 million patients. By the end of 2022, the number of current Walgreens Health Corners will expand from 55 to approximately 100 locations, which include the additional five in Ohio.

Walgreens Health Corner locations will offer eligible Ohio Medicaid members access to an integrated healthcare experience led by Health Advisors, who are pharmacists or registered nurses.

Health Advisors will provide a range of health and clinical services that supplement care received from primary care physicians and specialists. Patient care services and associated outcomes will be shared with Buckeye Health Plan and additional patient care providers to support individualized, holistic care.

The collaboration between Walgreens Health and Buckeye Health Plan highlights Walgreens Boots Alliance's new vision to be the leading partner in reimagining local healthcare and wellbeing for all.

This new collaboration follows a successful Walgreens Pharmacy pilot program launched with Buckeye Health Plan in 2021 to support asthma and COPD patients as part of a multi-phased approach to support comprehensive expanded clinical services.

read more
Walgreens To Close 1,200 US Stores

Walgreens To Close 1,200 US Stores

Walgreens announced its plan to close around 1,200 U.S stores over the next three years, including around 500 closures in fiscal 2025, as the drug store chain is facing a challenging U.S. retail environment amid increasing competition. The move, which was announced while reporting a significantly wider net loss in its fourth quarter, is expected to be immediately accretive to adjusted earnings...
RTTNews | 69日前
Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. will start selling abortion pill mifepristone this month at stores in several states where it is legal. Both companies have received certification from the U.S. Food and Drug Administration to dispense the pill at their retail pharmacies.
RTTNews | 295日前
FDA Warns CVS Health, Walgreens Against Unapproved Eye Products

FDA Warns CVS Health, Walgreens Against Unapproved Eye Products

The U.S. Food and Drug Administration has warned eight companies including CVS Health and Walgreens Boots Alliance, Inc. against manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. The agency has issued warning letters to these companies as part of its ongoing effort to protect Americans from potentially harmful ophthalmic products.
RTTNews | 468日前
Walgreens, Pearl Health Partner To Boost Value-Based Care Delivery

Walgreens, Pearl Health Partner To Boost Value-Based Care Delivery

Walgreens, a division of Walgreens Boots Alliance, Inc. (WBA), has inked a partnership with Pearl Health to boost and expand value-based care to patients in Medicare in partnership with community-based primary care physicians. The partnership with Pearl Health will enable Walgreens to transition quickly and effectively to value-based care and improve outcomes in the communities they serve.
RTTNews | 469日前
Walgreens Boots Alliance Slashes FY23 Adj. EPS Outlook; Stock Down 7% - Update

Walgreens Boots Alliance Slashes FY23 Adj. EPS Outlook; Stock Down 7% - Update

While reporting financial results for the third quarter on Tuesday, Walgreens Boots Alliance, Inc. (WBA) slashed its adjusted earnings guidance for the full-year 2023 to a range of $4.00 to $4.05 per share from the prior forecast range of $4.45 to $4.65 per share, reflecting challenging consumer and macroeconomic conditions, and lower COVID-19 vaccine and testing volumes.
RTTNews | 546日前